Generalitat de Catalunya Departament de Salut MORTALITY RISK FACTORS FOR THE FIRST YEAR OF HAEMODIALYSIS IN CATALONIA 1997-2002 J. M. Mauri 1, M. Clèries.

Slides:



Advertisements
Similar presentations
Risk Stratification in Renal Care Mary Jane McKendry Vice President, Operations Fresenius Disease Management Optimal Renal Care.
Advertisements

Socioeconomic Inequalities in Health Among Canadian Women with Heart Disease Arlene S. Bierman, M.D., M.S Ontario Womens Health Council Chair in Womens.
UK Renal Registry 17th Annual Report Figure Data completeness for key variables, stratified by first modality DOB = date of birth; PRD = primary.
UK Renal Registry 16th Annual Report Figure 5.1. Flow chart showing number of patients included in the various analyses.
The long-term outcome after acute renal failure Presented by Ri 顏玎安.
Prediction Models in Medicine Clinical Decision Support The Road Ahead Chapter 10.
Chapter 2: Identification and Care of Patients With CKD 2014 ANNUAL DATA REPORT VOLUME 1: CHRONIC KIDNEY DISEASE.
UK Renal Registry 16th Annual Report Figure 8.1. Trend in 1 year after 90 day incident patient survival by first modality, 2005–2011 cohort (adjusted to.
Chapter 3: Morbidity & Mortality 2014 ANNUAL DATA REPORT VOLUME 1: CHRONIC KIDNEY DISEASE.
Hemoglobin A 1c in Hemodialysis Patients Source: Ix JH. Hemoglobin A1c in hemodialysis patients: Should one size fit all? Clin J Am Soc Nephrol. 2010;5:1539–1541.
Chronic kidney disease Mr James Hollinshead Public Health Analyst East Midlands Public Health Observatory (EMPHO) UK Renal Registry 2011 Annual Audit Meeting.
Validation of Mayo Clinic Risk Adjustment Model for In-Hospital Mortality following Percutaneous Coronary Interventions using the National Cardiovascular.
UKRR Annual Informatics Meeting, September 2013 Highlights from the 15 th Annual Report Rishi Pruthi Research Fellow UK Renal Registry.
© ANZDATA Registry Method and Location of Dialysis 1453 (30%) 632 (13%) 1317 (27%) 1335 (27%) Number of Patients Australia 31-Dec-96.
Survival comorbidity Mrs Retha Steenkamp Senior Statistician UK Renal Registry UK Renal Registry 2011 Annual Audit Meeting.
Effect of Hypertension and Dyslipidemia on glycemic control among Type 2 Diabetes patients in Thailand Dr. Mya Thandar Dr.PH. Batch 5 1.
Presented by Dr. Soe Sandi Tint
Why don’t indigenous dialysis patients receive transplants – waitlist or allocation? N. Khanal 1, P. Clayton 1, S. McDonald 1, M. Jose 2 1 The University.
Division of Population Health Sciences Royal College of Surgeons in Ireland Coláiste Ríoga na Máinleá in Éirinn Indices of Performances of CPRs Nicola.
Improving the utility of comorbidity records Retha Steenkamp UK Renal Registry.
Haemodialysis Vascular Access: Recent Trends From ANZDATA Dr Kevan Polkinghorne Monash Medical Centre ANZSN September 2007.
Effect of Hypertension and Dyslipidemia on glycemic control among Type 2 Diabetes patients Dr. Mya Thandar.
Data completeness reporting Alex Hodsman, David Bull, Paul Dawson UK Renal Registry.
UK Renal Registry 17th Annual Report Figure 2.1. Prevalence rates per million population by age group and UK country on 31/12/2013.
UK Renal Registry 10th Annual Report 2007 Fig 3.1 Incident rates in the countries of the UK:
UK Renal Registry 17th Annual Report Figure 1.1. RRT incidence rates in the countries of the UK 1990–2013.
Highlights from the Annual Report UK Renal Registry 2013 Annual Audit Meeting Dr Catriona Shaw Registrar, UK Renal Registry.
Survival after graft failure Dr Lynsey Webb Registrar UK Renal Registry UK Renal Registry 2011 Annual Audit Meeting.
Evaluating Risk Adjustment Models Andy Bindman MD Department of Medicine, Epidemiology and Biostatistics.
Chapter 3 Mortality in End Stage Kidney Disease 2014 ANZDATA Registry 37th Annual Report Data to 31-Dec-2013.
2015 ANNUAL DATA REPORT V OLUME 2: E ND -S TAGE R ENAL D ISEASE Chapter 6: Mortality.
Chapter 2: Identification and Care of Patients With CKD 2015 A NNUAL D ATA R EPORT V OLUME 1: C HRONIC K IDNEY D ISEASE.
DEATHS CHAPTER 3. © ANZDATA Registry Figure 3.1 Survival among People who Commenced Dialysis 2001—2010 (Non-Indigenous) % (95% CI) Age at Start Time Period.
Heart Disease Example Male residents age Two models examined A) independence 1)logit(╥) = α B) linear logit 1)logit(╥) = α + βx¡
Logo Authors & Affiliations : Josep L Clua-Espuny (1), Teresa Forcadell-Arenas (1), Rosa Ripolles-Vicente (1), Panisello-Tafalla(1), Antonia González-Henares.
2015 ANNUAL DATA REPORT V OLUME 2: E ND -S TAGE R ENAL D ISEASE Chapter 5: Hospitalization.
2015 ANNUAL DATA REPORT V OLUME 2: E ND -S TAGE R ENAL D ISEASE Chapter 2: Healthy People 2020.
Long-term mortality and thrombolysis therapy after a first acute ischemic stroke: gender differences. Ebrictus II Study. Authors & Affiliations Clua-Espuny.
2015 ANNUAL DATA REPORT V OLUME 2: E ND -S TAGE R ENAL D ISEASE Chapter 4: Vascular Access.
What happens to patients returning to dialysis after transplant failure? Data from the UK Renal Registry Dr Lynsey Webb 1, Dr Anna Casula 1, Dr Charlie.
AID45(1/R17)- Is it a group with higher stroke risk (70-74 years). What is happening with the men? Ebrictus Project. Authors & Affiliations : Antonia González-Henares(1),
ANZDATA Registry Annual Report 2013 Philip Clayton CHAPTER 9 KIDNEY DONATION 2013 Annual Report - 36th Edition DEATHS CHAPTER 3.
Acute Renal Failure in HIV- Infected Individuals Greatly Increases Risk for In-Hospital Mortality Slideset on: Wyatt CM, Arons RR, Klotman PE, Klotman.
USRDS USRDS 2002 adr Incident counts by initial modality figure 7.1 patients age 19 years & younger.
2016 Annual Data Report, Vol 2, ESRD, Ch 5
2016 Annual Data Report, Vol 2, ESRD, Ch 6
When Using DOPPS Slides
Figure 10.1 Dialysis unit counts, by unit affiliation, 2011–2014
First-year death rates by modality figure 8
Patient populations by study group figure 10
Volume 2: End-Stage Renal Disease Chapter 4: Hospitalization
UK Renal Registry 16th Annual Report
2016 Annual Data Report, Vol 2, ESRD, Ch 4
Use of exercise tests in primary care: importance for referral decisions and possible bias in the decision process; a prospective observational study Gunnar.
Volume 1: Chronic Kidney Disease Chapter 3: Morbidity and Mortality
Volume 2: End-Stage Renal Disease Chapter 4: Hospitalization
Epidemiology of diabetic nephropathy in Spain
Chapter 3: Morbidity and Mortality
CHAPTER 3 DEATHS Stephen McDonald 2012 Annual Report—35th Edition
Fig 6.1 Frequency of ischaemic heart disease in incident patients
UK Renal Registry 14th Annual Report
2013 Annual Report - 36th Edition
UK Renal Registry 10th Annual Report 2007
UK Renal Registry 14th Annual Report
Update from the Haemodialysis Working Group
UK Renal Registry 16th Annual Report
Dialysis outcomes in Australia & New Zealand
ANZDATA: Vascular Access
Figure Prevalence of coronary artery disease by year or
Stock and Flow of Haemodialysis Patients Australia
Presentation transcript:

Generalitat de Catalunya Departament de Salut MORTALITY RISK FACTORS FOR THE FIRST YEAR OF HAEMODIALYSIS IN CATALONIA J. M. Mauri 1, M. Clèries 2, E. Vela 2 and RMRC 2. 1 Hospital Universitari de Girona “Dr Josep Trueta”, 2 Registre de Malalts Renals de Catalunya. OCATT, Servei Català de la Salut Sociedad Española de Nefrologia Málaga. Octubre, 2005

Generalitat de Catalunya Departament de Salut Mortality indicators: international comparison (2) 21,1 13,6 14,25 16,2 25,1 17,7 18,5 21,3 USRDS-(2001) Australia (ANZDATA)- (2002) Italy (Soc. Nefrol)-(2002) RMRC ( ) USRDS-(2001) Australia (ANZDATA)- (2002) UK- ( ) RMRC ( ) mortality per 100 patients/year HD DM

Generalitat de Catalunya Departament de Salut Causes of death. New cases on HD

Generalitat de Catalunya Departament de Salut Objective To analyze the risk factors related to early mortality (90 days), and the mortality at 6 months and in the first year after starting haemodialysis, on the patients entered in the period

Generalitat de Catalunya Departament de Salut Methods (1) Data Source: Catalan Renal Registry (RMRC).Health Department of the Government of Catalonia The RMRC was created in 1984 Declaration is obligated for all patients admitted on RRT in Catalonia On time up-date for changing modality of RRT and mortality, and Annual up-date for morbidity, mortality, vascular access and the usual those clinical and biological parameters.

Generalitat de Catalunya Departament de Salut Methods (2) Patients: All patients older than 14 who initiated HD in Catalonia on the period (n=4,704). Information about all variables was available for 4,579 (97.3% of all patients)

Generalitat de Catalunya Departament de Salut Methods (3) Risk Factors studied: AgeSex Primary renal diseaseCardiac diseases StrokeArrythmia Peripheral vascular diseasesMalignancies Liver Chronic diesasesOPD TuberculosisInfection Arthropaty Gut diseases Esoph., stomach& duod. Presentation of ESRD 1st Vascular access Functional autonomy degree

Generalitat de Catalunya Departament de Salut Methods (4) Statistics:  2 for comparison of proportions. Logistic Regression to identify the risk factors associated to early death (90 days, 6 moths & 1 year). Signification was adjusted for p<0.05. An examination of all possible two-way interactions are tested. Calibration was assessed using Hosmer-Lemeshow goodness-of-fit test and discrimination using the area under the receiver operating characteristics (ROC) curve.

Generalitat de Catalunya Departament de Salut Mortality rates and Standard Mortaliy Index (SMI) on the first year of HD after age group >84GLOBAL Age group Rates per 1,000 Catalonia 2000HD Referred to the Catalan Population >84GLOBAL Age group SMI IC 95%IME

Generalitat de Catalunya Departament de Salut Causes of Death after Age Group >84 Age at HD start Mortality per 100 patients / year CardiovascularInfectionCancer

Generalitat de Catalunya Departament de Salut Adjusted (*) Odds Ratios for Age (10 years). OR at 90 daysOR at 6th monthsOR at 1 year 0,2 2...

Generalitat de Catalunya Departament de Salut CRF Presentation at HD start after Age Group and adjusted (*) Odds Ratio (*)Adjusted for Age, Gender, Functional Autonomy Degree, Associate Morbidities, CRF Presentation and first choice Vascular Access.. Unknown Descompensation Unknown Descompensation Unknown Descompensation 0,2 2 OR at 90 daysOR at 1st yearOR at 6 months.....

Generalitat de Catalunya Departament de Salut OCPD at HD start after Age Group and adjusted (*) Odds Ratio (*)Adjusted for Age, Gender, Functional Autonomy Degree, Associate Morbidities, CRF Presentation and first choice Vascular Access.. OR at 90 daysOR at 6th monthOR at 1st year 0,2 2..

Generalitat de Catalunya Departament de Salut Malignancies at HD start after Age Group and adjusted (*) Odds Ratio (*)Adjusted for Age, Gender, Functional Autonomy Degree, Associate Morbidities, CRF Presentation and first choice Vascular Access.. OR at 90 daysOR at 6th monthOR at 1st year 0,2 2..

Generalitat de Catalunya Departament de Salut Chronic liver dis. at HD start after Age Group and adjusted (*) Odds Ratio. OR at 90 daysOR at 6th monthOR at 1st year 0,2 2.. (*)Adjusted for Age, Gender, Functional Autonomy Degree, Associate Morbidities, CRF Presentation and first choice Vascular Access.

Generalitat de Catalunya Departament de Salut PRD at HD Start after Age Group and adjusted (*) Odds Ratios.. DNSystemic D.DNSystemic D.DNSystemic D. 0, 2 2 OR at 90 DaysOR at 1 YearOR at 6 Months (*)Adjusted for Age, Gender, Functional Autonomy Degree, Associate Morbidities, CRF Presentation and first choice Vascular Access < >84 Age at start of HD Percentage DiabetesSystemic dis.

Generalitat de Catalunya Departament de Salut Ischaemic Cardiopathy at the HD start after age group, and adjusted (*) Odds Ratios. (*)Adjusted for Age, Gender, Functional Autonomy Degree, Associate Morbidities, CRF Presentation and first choice Vascular Access.. OR at 90 daysOR at 6th monthOR at 1st year 0,2 2..

Generalitat de Catalunya Departament de Salut Arrythmia at HD start after Age Group and adjusted (*) Odds Ratio (*)Adjusted for Age, Gender, Functional Autonomy Degree, Associate Morbidities, CRF Presentation and first choice Vascular Access.. OR at 90 daysOR at 6th monthOR at 1st year 0,2 2..

Generalitat de Catalunya Departament de Salut Functional Autonomy Degree at HD start after Age Group and adjusted (*) Odds Ratio.. LimitedSpecial careLimitedSpecial careLimitedSpecial care 0, OR at 90 daysOR at 1st yearOR at 6 months.... (*)Adjusted for Age, Gender, Functional Autonomy Degree, Associate Morbidities, CRF Presentation and first choice Vascular Access.

Generalitat de Catalunya Departament de Salut Catheter as a first VA at HD start after Age group and adjusted (*) Odds Ratio. OR at 90 daysOR at 6th monthOR at 1st year 0,2 2.. (*)Adjusted for Age, Gender, Functional Autonomy Degree, Associate Morbidities, CRF Presentation and first choice Vascular Access.

Generalitat de Catalunya Departament de Salut Predictive models at 90 days, 6 months and 1 year Mathematical Model: π(x)= e βo+β1x 1+ e βo+β1x β: 90 days6 months1st year Sex (female) Age PRD: diabetes systemic Funct. autonomy degree: limited special care Ischaemic heart dis Cardiomyopathy Arrythmia OCPD Malignancies Chronic liver disease CRF Presentation: unknown descompensation Catheter β 0 - 7,

Generalitat de Catalunya Departament de Salut Exemples Man, 69 with Standard PRD, Descompensated CRF and limited FAD, and with Ischaemic heart disease. Man, 49 with Standard PRD, normal FAD, normal CRF Presentation and with associated Ischaemic heart disease.

Generalitat de Catalunya Departament de Salut Conclusions  Early mortality correlated with age, systemic PRD, arrythmia and OCPD  A strong correlation was found for patients starting HD with cardiovascular disease, catheter as first vascular access or suffering from a low functional autonomic level.  At six months Diabetes (both as PRD or co-morbidity) and late referral were found significant.  At one year, diabetes (both as PRD or comorbidity), ischaemic heart disease, arythmia and malignances attained signification.  A model-based predictive model may be suggested.  Further analysis are required to validate the model and to identify the correspondence degrees between either individual or associate morbid conditions as seen at the HD start and the cause of the death.